A randomized, double-blind, placebo-controlled trial showed that a brief treatment with metronidazole followed by inulin supplementation could reduce alanine aminotransferase (ALT) levels in patients with NAFLD [8]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.